1. Home
  2. Analysis
  3. Capecitabine
  4. Proventil

Capecitabine and Proventil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Capecitabine (capecitabine) and Proventil (albuterol). Common drug interactions include erythema among females and disease progression among males.

The phase IV clinical study analyzes what interactions people have when they take Capecitabine and Proventil. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Capecitabine?

Capecitabine has active ingredients of capecitabine. eHealthMe is studying from 59,495 Capecitabine users. Check the latest studies of Capecitabine.

What is Proventil?

Proventil has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 16,110 Proventil users. Check the latest studies of Proventil.

On Jul, 15, 2026

16 people who take Capecitabine and Proventil together, and have interactions are studied.

Capecitabine and Proventil drug interactions.

What are the common drug interactions of Capecitabine and Proventil, by gender? *:

female:

  1. Erythema (redness of the skin)
  2. Eye disorder
  3. Eye irritation
  4. Full blood count decreased
  5. Peripheral swelling
  6. Productive cough
  7. Pyrexia (fever)
  8. Skin discolouration (change of skin colour)
  9. Skin exfoliation (removal of the oldest dead skin cells)
  10. Vomiting

male:

  1. Disease progression
  2. Death
  3. Drug ineffective

What are the common drug interactions of Capecitabine and Proventil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dehydration (dryness resulting from the removal of water)
  2. Diarrhoea
  3. Disease progression
  4. Full blood count decreased
  5. Vomiting

50-59:

  1. Disease progression

60+:

  1. Disease progression
  2. Arthralgia (joint pain)
  3. Productive cough
  4. Pyrexia (fever)
  5. Skin discolouration (change of skin colour)
  6. Skin exfoliation (removal of the oldest dead skin cells)
  7. Chills (felling of cold)
  8. Death
  9. Drug ineffective
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Colon Cancer: 4 people, 25.00%
  2. Breast Cancer: 4 people, 25.00%
  3. Breast Cancer Female: 3 people, 18.75%
  4. Rectal Cancer (cancer of rectum): 1 person, 6.25%
  5. Neoplasm Malignant (cancer tumour): 1 person, 6.25%
  6. Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Capecitabine and Proventil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Capecitabine and Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Capecitabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Capecitabine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proventil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on capecitabine and albuterol (the active ingredients of Capecitabine and Proventil, respectively), and Capecitabine and Proventil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.